Select Transactions

Debt Recapitalization and Acquisition of NextWave Pharmaceuticals from
$125 million
September 2018
Somerset Therapeutics
and affiliate Wintac, Limited acquired by
$190 million
April 2018
Acquisition of
generics business of
$1.05 billion
June 2017
Mallinckrodt Pharmaceuticals
Sale of
Intrathecal business to
$203 million
March 2017
Torreya is a leading strategic M&A advisor to global life sciences companies.   MORE
Torreya is one of the most active financial advisors on pharmaceutical-product asset sales.   MORE
Torreya’s Capital Markets team arranges debt financings, royalty monetizations, IPOs, and private equity recapitalizations.   MORE
Torreya is a leading advisor on pre-commercial and commercial-stage licensing deals.   MORE

The Future of the Global Pharmaceutical Industry

Torreya finds the global pharmaceutical industry is larger, innovating more rapidly, and likely to experience higher growth than previously thought.

Click here for Report Executive Summary   |    Click here for full Future of Global Pharmaceutical Industry Report

1 Based on Torreya econometric model relating OECD estimates of future GDP growth to growth estimates for the pharmaceutical sector.